BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• BioForest

  Alder Biopharmaceuticals Inc. Announces Addition To NASDAQ Biotechnology Index

  December 17, 2014

   · 

  3 min read
• Biotech Bay

  Relypsa, Inc. To Be Added To NASDAQ Biotechnology Index

  December 17, 2014

   · 

  1 min read
• Genetown

  SAGE Therapeutics Added To NASDAQ Biotechnology Index

  December 17, 2014

   · 

  4 min read
• Drug Development

  Stemline Therapeutics, Inc. Initiates SL-401 Clinical Trial In Four Rare Myeloproliferative Neoplasms

  December 17, 2014

   · 

  4 min read
• Lone Star Bio

  Phenogen Sciences, Inc. Announces Clinical Validation Study Supporting The Use Of Brevagenplus® In Breast Cancer Risk Assessment

  December 17, 2014

   · 

  3 min read
• Deals

  Emergent BioSolutions Expands Biodefense Franchise; Acquires Portfolio Of Broad Spectrum Antibiotics

  December 17, 2014

   · 

  5 min read
• BioBlast Pharma Receives Notice Of Patent Issuance From USPTO For Its Novel Fusion Protein-Based Platform For The Treatment Of Friedrich’s Ataxia

  December 17, 2014

   · 

  3 min read
• Genetown

  Agios Pharmaceuticals Announces Closing Of Public Offering And Full Exercise Of Over-Allotment Option

  December 17, 2014

   · 

  3 min read
• Policy

  Pozen, Inc.’s YOSPRALA™ Receives Complete Response Letter From The FDA

  December 17, 2014

   · 

  7 min read
• Drug Development

  Ablynx Opens Recruitment For First-In-Infant Phase 2a Study With Its Anti-Rsv Nanobody, ALX-0171

  December 17, 2014

   · 

  5 min read